Eagle Pharmaceuticals Reiterates 2023 Adjusted EBITDA and EPS Guidance By Investing.com
Eagle Pharmaceuticals (EGRX) Reiterates 2023 Adjusted EBITDA and EPS Guidance Eagle Pharmaceuticals, Inc. (Nasdaq: NASDAQ:) (“Eagle” or the “Company”) today…
Badger Infrastructure Solutions Ltd. Announces Record 2023 Second Quarter Revenue and Adjusted EBITDA
This section is Partnership Content supplied The content in this section is supplied by GlobeNewswire for the purposes of distributing…
